SKI Market

A+| A| A-|

Indian Indices

Sensex

78,493.54 504.86
( 0.65%)

Global Indices

Nasdaq

49,467.44 867.71
(1.79%)

Dow Jones

7,146.92 84.64
(1.20%)

Hang Seng

58,837.37 -680.97
(-1.14%)

Nikkei 225

10,660.47 70.48
(0.67%)

Forex

USD-INR

93.19 -0.12
(-0.13%)

EUR-INR

109.85 -0.18
(-0.16%)

GBP-INR

126.25 -0.31
(-0.25%)

JPY-INR

0.59 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Biogen Pharmachem Industries Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

531752

INE703D01023

1.0977251

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

43.32

EPS(TTM)

Face Value()

Div & Yield %

0.03

Back

Ingersoll-Rand (India) reports standalone net profit of Rs 60.35 crore in the September 2025 quarter

Nov 14,2025

Net profit of Ingersoll-Rand (India) remain constant at Rs 60.35 crore in the quarter ended September 2025 and also during the previous quarter ended September 2024. Sales declined 0.05% to Rs 321.94 crore in the quarter ended September 2025 as against Rs 322.10 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	321.94	322.10	0
OPM %	23.56	24.60	-
PBDT	84.42	85.43	-1
PBT	80.85	80.95	0
NP	60.35	60.35	0

78,493.54 504.86 ( 0.65%)

49,467.44 867.71 (1.79%)

7,146.92 84.64 (1.20%)

58,837.37 -680.97 (-1.14%)

10,660.47 70.48 (0.67%)

93.19 -0.12 (-0.13%)

109.85 -0.18 (-0.16%)

126.25 -0.31 (-0.25%)

0.59 0.00 (-0.15%)